Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota

被引:94
作者
Kao, Amy Chia-Ching [1 ]
Spitzer, Sonia [1 ]
Anthony, Daniel C. [2 ]
Lennox, Belinda [1 ]
Burnet, Philip W. J. [1 ]
机构
[1] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England
[2] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England
基金
英国生物技术与生命科学研究理事会;
关键词
CHAIN FATTY-ACIDS; RANDOMIZED CONTROLLED-TRIAL; TUMOR-NECROSIS-FACTOR; DIET-INDUCED OBESITY; NMDA RECEPTOR; ANTIPSYCHOTIC-DRUGS; METABOLIC SYNDROME; IMMUNE FUNCTION; BODY-WEIGHT; SCHIZOPHRENIA;
D O I
10.1038/s41398-018-0116-8
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Olanzapine is an effective antipsychotic drug but since it causes significant weight gain, it is not well tolerated by psychosis patients. The prebiotic, B-GOS (R), attenuates metabolic dysfunction in obese subjects, and in rodents, alters central NMDA receptors and may affect serotonin receptors that are relevant in psychosis. We have determined whether B-GOS (R) influenced olanzapine-associated weight gain and central NMDA and serotonin receptors. Circulating acetate, IL-1 beta, IL-8 and TNF alpha, liver acetyl-CoA carboxylase (ACC), white adipose tissue (WAT) acetate receptor GPR43, and specific faecal bacteria genera were also measured to provide mechanistic information. Adult female Sprague-Dawley rats were administered a B-GOS (R) (0.5 g/kg/day) solution or water for 21 days, and received a single, daily, intraperitoneal injection of olanzapine or saline on days 8-21. The intake of B-GOS (R) significantly attenuated olanzapine-induced weight gain without altering frontal cortex 5-HT2AR blockade. Cortical GluN1 levels were elevated by olanzapine in the presence of B-GOS (R). Plasma acetate concentrations increased following B-GOS (R) or olanzapine administration alone, but reduced when prebiotic and drug were administered in combination. This pattern was paralleled by hepatic ACC mRNA expression. The abundance of WAT GPR43 mRNA was reduced by olanzapine, only in the absence of B-GOS (R). Co-administration of B-GOS (R) and olanzapine also elevated plasma TNFa, which is reported to influence lipid metabolism. Finally, B-GOS (R) elevated faecal Bifidobacteriumspp. and reduced some bacteria in the Firmicutes phylum, whilst olanzapine treatment either alone or with B-GOS (R), was without effect. These data suggest that inclusion of B-GOS (R) as an adjunct to olanzapine treatment in schizophrenia may prevent weight gain and have benefits on cognitive function in psychosis. The role of acetate in these effects requires further investigation.
引用
收藏
页数:12
相关论文
共 63 条
[1]  
Allison DB, 1999, AM J PSYCHIAT, V156, P1686
[2]   Glucagon-Like Peptide 1 and Its Analogs Act in the Dorsal Raphe and Modulate Central Serotonin to Reduce Appetite and Body Weight [J].
Anderberg, Rozita H. ;
Richard, Jennifer E. ;
Eerola, Kim ;
Lopez-Ferreras, Lorena ;
Banke, Elin ;
Hansson, Caroline ;
Nissbrandt, Hans ;
Berqquist, Filip ;
Gribble, Fiona M. ;
Reimann, Frank ;
Asterholm, Ingrid Wernstedt ;
Lamy, Christophe M. ;
Skibicka, Karolina P. .
DIABETES, 2017, 66 (04) :1062-1073
[3]  
[Anonymous], MOL PSYCHIAT
[4]   Antipsychotic medications and extreme weight gain in two health systems [J].
Arterburn, David ;
Wood, G. Craig ;
Theis, Mary Kay ;
Westbrook, Emily O. ;
Anau, Jane ;
Rukstalis, Margaret ;
Boscarino, Joseph A. ;
Daar, Zahra ;
Gerhard, Glenn S. .
OBESITY RESEARCH & CLINICAL PRACTICE, 2016, 10 (04) :408-423
[5]   Mechanisms underlying the resistance to diet-induced obesity in germ-free mice [J].
Backhed, Fredrik ;
Manchester, Jill K. ;
Semenkovich, Clay F. ;
Gordon, Jeffrey I. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (03) :979-984
[6]   Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children [J].
Bahr, S. M. ;
Tyler, B. C. ;
Wooldridge, N. ;
Butcher, B. D. ;
Burns, T. L. ;
Teesch, L. M. ;
Oltman, C. L. ;
Azcarate-Peril, M. A. ;
Kirby, J. R. ;
Calarge, C. A. .
TRANSLATIONAL PSYCHIATRY, 2015, 5 :e652-e652
[7]   Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure [J].
Bahr, Sarah M. ;
Weidemann, Benjamin J. ;
Castro, Ana N. ;
Walsh, John W. ;
Deleon, Orlando ;
Burnett, Colin M. L. ;
Pearson, Nicole A. ;
Murry, Daryl J. ;
Grobe, Justin L. ;
Kirby, John R. .
EBIOMEDICINE, 2015, 2 (11) :1725-1734
[8]   Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis [J].
Bak, Maarten ;
Fransen, Annemarie ;
Janssen, Jouke ;
van Os, Jim ;
Drukker, Marjan .
PLOS ONE, 2014, 9 (04)
[9]   Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice [J].
Burokas, Aurelijus ;
Arboleya, Silvia ;
Moloney, Rachel D. ;
Peterson, Veronica L. ;
Murphy, Kiera ;
Clarke, Gerard ;
Stanton, Catherine ;
Dinan, Timothy G. ;
Cryan, John F. .
BIOLOGICAL PSYCHIATRY, 2017, 82 (07) :472-487
[10]   Pro-inflammatory cytokines and adipose tissue [J].
Coppack, SW .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2001, 60 (03) :349-356